Additional Locations, Illinois Clinical Trials

A listing of Additional Locations, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2023 clinical trials
featured
A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis

www.MyelofibrosisResearch.com This is a Phase 2 open-label, multicenter study evaluating tolerability and efficacy of navitoclax alone or when added to ruxolitinib in participants with myelofibrosis.

Rush University Medical Center /ID# 230057
 (3.0 away) Contact site
  • 254 views
  • 29 Apr, 2021
  • +134 other locations
featured
A Study to Evaluate the Safety Tolerability and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease

The primary objective of this study is to evaluate the safety and tolerability of single and multiple doses of BIIB094 administered via intrathecal (IT) injection to participants with Parkinson's Disease (PD). The secondary objective of this study is to evaluate the pharmacokinetic (PK) profile of BIIB094.The study is open for …

dyskinesia
Northwestern University Feinberg School of Medicine
 (1.9 away) Contact site
  • 250 views
  • 25 May, 2021
  • +13 other locations
featured
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

www.MyelofibrosisResearch.com Myelofibrosis is a type of bone marrow cancer that usually develops slowly and disrupts body's normal production of blood cells. It causes bone marrow scarring, leading to severe anemia that can cause weakness and fatigue. It can also cause a low number of blood-clotting cells called platelets, which increases …

Rush University Medical Center /ID# 221581
 (3.0 away) Contact site
  • 32 views
  • 29 Apr, 2021
  • +148 other locations
featured
Study in Parkinson Disease of Exercise

This study is a Phase 3 multi-site, randomized, evaluator-masked, study of endurance treadmill exercise on changes in the Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS) Part III score at 12 months among persons with early stage Parkinson disease. 370 participants will be randomly assigned to 2 groups: 1)60-65% HRmax …

Northwestern University
 (1.9 away) Contact site
  • 0 views
  • 04 Jun, 2021
  • +7 other locations
featured
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

The objective of the RADIANCE II Pivotal study is to demonstrate the effectiveness and safety of the Paradise System in subjects with Stage 2 hypertension on 0-2 medications at the time of consent. Prior to randomization, subjects will be hypertensive in the absence of hypertension medication.

hypertension
angiography
renal angiogram
antihypertensive drugs
hypertensive medication
Northwestern University
 (1.9 away) Contact site
  • 877 views
  • 01 Aug, 2021
  • +82 other locations
featured
A Phase 2, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement

This is an open-label, monotherapy study of INCB054828 in subjects with myeloid/lymphoid neoplasms with FGFR1 rearrangement.  Subjects will receive a once daily (QD) dose of INCB054828 at 13.5 mg on a 2-week-on–therapy and 1-week-off–therapy schedule.  With Protocol Amendment 3, the administration schedule will be adjusted, and newly enrolled subjects will …

myeloid neoplasm
lymphoid malignancy
FGFR1
The University of Chicago Medical Center
 (9.4 away) Contact site
  • 79 views
  • 14 Dec, 2020
  • +34 other locations
featured
A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma - (FIGHT-302)

The purpose of this study is to evaluate the efficacy and safety of pemigatinib versus gemcitabine plus cisplatin chemotherapy in first-line treatment of participants with unresectable or metastatic cholangiocarcinoma with FGFR2 rearrangement.  

primary cancer
metastatic cancer
cancer
FGFR2
University of Chicago Medical Center
 (9.4 away) Contact site
  • 157 views
  • 14 Dec, 2020
  • +154 other locations
featured
[ONLINE] Genetic Testing for Common Disorders: Learning from the Experiences of Individuals who were Tested to Determine their Genetic Risk for Alzheimer’s Disease

This study is looking for people who have the APOE-e4 gene, which is associated with a higher risk for developing Alzheimer’s disease. The study is interested in learning about participants’ experiences. Contact Person Doris T. Zallen 540-231-4216dtzallen@vt.edu IMPORTANT: This communication is meant only to make you aware of an opportunity …

Online3
 (2.7 away) Contact site
  • 432 views
  • 17 Nov, 2020
  • +251 other locations
featured
[ONLINE] Dementia dogs: Their impact on community-dwelling persons with mild to moderate dementia

  This study is looking for pairs of participants: a person with mild-to-moderate dementia, and their caregiver. The study is interested in the difference that dogs can make in participants’ lives. Contact Person Frederic Dumont 1 418 529-9141 ext 6033frederic.dumont@cirris.ulaval.ca

moderate dementia
Online3
 (2.7 away) Contact site
  • 20 views
  • 12 Oct, 2020
  • +250 other locations
featured
[ONLINE] Daily Reflections of Dementia Caregivers

This study is looking for caregivers of family members who have mild cognitive impairment or dementia. This is a survey study that is interested in learning about caregivers’ experiences. Contact Person Dr. Carolyn Pickering 210-560-3075 pickeringc@uthscsa.edu Study Website:www.caregivingresearch.org/daily-reflections

Online3
 (2.7 away) Contact site
  • 79 views
  • 28 Jan, 2021
  • +252 other locations